丹麦全国性研究:老年房颤患者口服抗凝药使用与临床结局的时间趋势
结果显示各年龄组卒中风险均下降,但≥85岁患者改善幅度较小且脑出血风险增加。
要点
- 2022年≥85岁房颤患者口服抗凝药使用比例达71%。
- 5年无卒中生存绝对改善:65-74岁10.1%,75-84岁12.8%,≥85岁仅3.5%。
- 75-84岁和≥85岁患者5年脑出血绝对风险增加。
核心结论
- 过去二十年所有年龄组房颤患者卒中风险显著下降,65-74岁组在口服抗凝药几乎全面实施时代未出现出血风险增加。
- ≥85岁患者卒中风险仅轻微改善,且脑出血风险增加。
主要发现
- 2022年≥85岁房颤患者口服抗凝药使用比例为71%。
- 5年无卒中生存绝对改善:65-74岁组10.1%,75-84岁组12.8%,≥85岁组3.5%。
- 75-84岁和≥85岁房颤患者5年脑出血绝对风险增加。
临床怎么用
- 对65-74岁房颤患者,口服抗凝药全面实施下卒中风险降低且未增加出血风险。
- 对≥85岁房颤患者,需权衡卒中预防与脑出血风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Anticoagulation therapy in patients with atrial fibrillation (AF) has changed over time, particularly following the introduction of direct oral anticoagulants. However, it is unknown how the uptake of anticoagulation therapy and the related clinical outcomes in elderly patients with AF have changed over time. METHODS: Patients with new-onset AF were included and divided into three age groups: older adults (65-74 years), elderly (75-84 years), and very elderly (≥85 years). Temporal trends in the initiation of oral anticoagulants (OACs), the stroke-free survival, major bleedings including intracerebral haemorrhage (ICH), and all-cause mortality were investigated from 1999 to 2022. RESULTS: In total, 243 938 patients were included, of whom 89 184 (36.6%) were older adults, 99 002 were elderly (40.6%), and 55 752 (22.8%) were very elderly. The proportion of very elderly patients with AF receiving OACs was 71% in 2022. The absolute improvement in the 5-year probability of stroke-free survival was 10.1% in the older adult patients, 12.8% in the elderly patients, and 3.5% in the very elderly patients. The 5-year absolute risk of ICH increased among the elderly and very elderly AF patients. CONCLUSIONS: Over the past two decades, the risk of stroke decreased significantly among all age groups, with no subsequent increase in the risk of bleeding among older adults in an era where OACs were almost fully implemented. In the very elderly patients aged ≥85 years, the risk of stroke only slightly improved over time, with an increase in the risk of ICH.
引用
- Binding, Elmegaard, Larsen, et al. Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study. Eur Heart J. 2026. PMID: 41251006. doi:10.1093/eurheartj/ehaf877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。